Fig. 1.

G2/M cell cycle arrest in lung adenocarcinoma cells after carfilzomib treatment

After treatment of carfilzomib (CFZ; 25 nmol/L) for 24 h, HCC-827 (a, b) and NCI-H1299 (c, d) cells were harvested and subjected to flow cytometry analysis. The percentage of cells in each phage was presented as mean±standard error (SE), n=3. ^** P<0.01